Site updated at Wednesday, 22 June 2016

Living with Dementia


Groups convince FDA to ease Alzheimer’s trial rules

Academic and industry experts said on Tuesday they have convinced U.S. regulators to ease safety restrictions imposed on clinical trials of Alzheimer’s drugs, a move that could improve the chances that a drug being developed jointly by Pfizer and Johnson & Johnson might succeed.

A 2008 study of 240 patients testing that drug, known… Groups convince FDA to ease Alzheimer’s trial rules   

Out of the shadows - Living with dementia

dementia causes3 - diet high in carbohydrates1 - alzheimer's disease195 - dementia135 - abeta1 - abstract thinking1 - congestive heart failure1 - functional imaging1 - stage dementia1 - islet amyloid polypeptide1 - dopamine deficiency1 - delay dementia1 - overweight1 - arnold pick1 - late-day anxiety1 - memantine1 - vascular health1 - greek paranoia1 - vascular dementia warning signs1 - dopamine-producing neurons4 - alzheimer's epidemic1 - quality of care2 - symptoms of alzheimer's2 - tau3 - repair damaged nerve tissue1 - phosphorylated alpha-synuclein1 - glucose hypometabolism1 - peanut butter1 - parkinson's diagnosis1 - risk of developing parkinson's1 -